Preface

Cancer is the second leading cause of human mortality worldwide, and researches in the field are enormous to fight against the deadly disease. The huge research on cancer includes cancer biomarker development, diagnosis and detection method development, cellular & molecular characterization of cancers, target identification, therapy development, clinical management, and so on. Since the clinical outcome of patients with cancer largely depends on early and proper diagnosis of the disease, thus, significant efforts on cancer biomarker research are going based on cancer biomarkers for detection, diagnosis, prognosis, therapy response, molecular typing, classification and stratification of cancers. Therefore, this book, Current Cancer Biomarkers, provides a comprehensive review based on the current status of biomarkers for various types of cancer, which could give great potential in disseminating the knowledge and information to a broad range of readers.

This book starts with an introduction to the basic characteristics of cancer biomarkers, which are used for various cancer treatments, and the biomarkers are under development. The next major portion of the book highlights the potential and effective biomarkers such as genomic, epigenomic, transcriptomic, and proteomics, cellular and morphologic factors associated with cancer, indicating the occurrence of cancers. The other part of the book discusses novel technologies to detect and analyse potential cancer biomarkers in point-of-care applications.

This book provided an all-inclusive review and the most updated information based on different aspects of cancer markers in the clinical setting. We hope that the topics covered in this book are useful and enrich our understanding of the disease, which could help better manage patients with cancers.

I am thankful to all the Authors and the editorial staff from Bentham Science for their contribution and support.